Moreover, treatment with rCCL2 increased paxillin phosphorylation in tumor cells (mean: 3.13), while CCR4 inhibition decreased p-paxillin amounts (mean: 1.06) (Figure 5, C and F). Here, PXN is linked to neoplasm.